on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation...may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.